Capitolis Liquid Global Markets’s Bristol-Myers Squibb BMY Stock Holding History

Capitolis Liquid Global Markets’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8M	Buy	240,100 +140,100	+140%	+$8.04M	0.06%	176
2026 Q1	$6.07M	Sell	100,000 -179,710	-64%	-$10.5M	0.04%	234
2025 Q4	$15.1M	Buy	279,710 +73,710	+36%	+$3.55M	0.09%	129
2025 Q3	$9.29M	Sell	206,000 -733,200	-78%	-$34.2M	0.07%	143
2025 Q2	$43.5M	Buy	+939,200	New	+$46.1M	0.32%	60
2024 Q1	–	Sell	-869,500	Closed	-$44.6M	–	120
2023 Q4	$44.6M	Buy	+869,500	New	+$45.6M	1.83%	18

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capitolis Liquid Global Markets's BMY Position: Q2 2026 in Review

Capitolis Liquid Global Markets increased its Bristol-Myers Squibb (BMY) stake by 140% in Q2 2026, buying an estimated $8.04M and bringing the position to 240,100 shares worth $13.8M. The position accounts for 0.06% of the portfolio, ranked #176.

Capitolis Liquid Global Markets first reported a position in BMY in Q4 2023 and has held it in 6 quarters since. The position peaked at $44.6M in Q4 2023. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Capitolis Liquid Global Markets held 240,100 shares of Bristol-Myers Squibb worth $13.8M as of Q2 2026.
Capitolis Liquid Global Markets bought 140,100 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.04M.
Bristol-Myers Squibb made up 0.06% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #176 holding.
Capitolis Liquid Global Markets first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 6 quarters since.
Capitolis Liquid Global Markets's Bristol-Myers Squibb position peaked at $44.6M in Q4 2023.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.